Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

H. Lee Moffitt Cancer Center and Research Institute

9 clinical trials · 9 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by H. Lee Moffitt Cancer Center and Research Institute

RECRUITINGNCT07018986

The MIND-BC Study: MIND Diet for Breast Cancer Cognition

This fully, powered efficacy RCT, the MIND diet for Breast Cancer Cognition (MIND-BC), will evaluate the MIND diet in a rigorous, highly controlled academic cancer center. We will...

Sponsor: H. Lee Moffitt Cancer Center and Research InstituteEnrolling: 2001 location
Breast Cancer
RECRUITINGNCT05665504

Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung...

This study is an observational study of blood and tissue biomarkers. Investigators plan to evaluate the accuracy of lung cancer biomarkers found in the blood in determining if a...

Sponsor: H. Lee Moffitt Cancer Center and Research InstituteEnrolling: 2501 location
Lung; NodeAdenocarcinoma of Lung
RECRUITINGPhase 2NCT05524935

Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma

This is a prospective phase II multi-center trial of the combination of the PARP inhibitor olaparib with the immune checkpoint inhibitor pembrolizumab in advanced uveal melanoma.

Sponsor: H. Lee Moffitt Cancer Center and Research InstituteEnrolling: 371 location
Uveal MelanomaOcular Melanoma
RECRUITINGPhase 2NCT04996823

Axitinib + Ipilimumab in Advanced Melanoma

The goal of this clinical research study is to find out if taking axitinib with ipilimumab is effective in treating advanced melanoma.

Sponsor: H. Lee Moffitt Cancer Center and Research InstituteEnrolling: 251 location
Melanoma
RECRUITINGPhase 1NCT05581030

CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

The purpose of the study is to evaluate the safety and tolerability of the study drug, calaspargase pegol, when given with multi-agent chemotherapy.

Sponsor: H. Lee Moffitt Cancer Center and Research InstituteEnrolling: 71 location
Acute Lymphoblastic Leukemia
RECRUITINGPhase 2NCT06855212

Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC

The purpose of the study is to determine if cemiplimab in combination with cetuximab given before their surgery are beneficial and safe in participants with head and neck squamous...

Sponsor: H. Lee Moffitt Cancer Center and Research InstituteEnrolling: 211 location
Head and Neck Squamous Cell Carcinoma
RECRUITINGPhase 1NCT07194044

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

This single arm study is designed to demonstrate the feasibility of a radically different approach for an exceptionally high-risk subset of MES with widely metastatic disease...

Sponsor: H. Lee Moffitt Cancer Center and Research InstituteEnrolling: 1517 locations
Metastatic Ewing Sarcoma
RECRUITINGPhase 2NCT05301283

Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma

The purpose of the study is to utilize radiomic images to precisely locate areas of tumor that can be treated with dose escalation radiation therapy.

Sponsor: H. Lee Moffitt Cancer Center and Research InstituteEnrolling: 431 location
High Grade Sarcoma
RECRUITINGNCT06745895

Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening

This innovative Multilevel Action Toward Colorectal Cancer (CRC) and Hepatitis C Virus (HCV) Education and Screening (MATCHES) intervention aims to promote concurrent HCV and CRC...

Sponsor: H. Lee Moffitt Cancer Center and Research InstituteEnrolling: 3501 location
Colorectal Cancer ScreeningHepatitis C Virus